0001628280-22-000416.txt : 20220106 0001628280-22-000416.hdr.sgml : 20220106 20220106095127 ACCESSION NUMBER: 0001628280-22-000416 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220104 FILED AS OF DATE: 20220106 DATE AS OF CHANGE: 20220106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huber Reid M CENTRAL INDEX KEY: 0001607052 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36783 FILM NUMBER: 22513828 MAIL ADDRESS: STREET 1: C/O INCYTE CORPORATION, EXPERIMENTAL STN STREET 2: ROUTE 141 & HENRY CLAY ROAD, BLDG. E336 CITY: WILMINGTON STATE: DE ZIP: 19880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0001358403 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201450200 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3730 KIRBY DRIVE STREET 2: SUITE 1200 CITY: HOUSTON STATE: TX ZIP: 77098 BUSINESS PHONE: (832) 384-1100 MAIL ADDRESS: STREET 1: 3730 KIRBY DRIVE STREET 2: SUITE 1200 CITY: HOUSTON STATE: TX ZIP: 77098 FORMER COMPANY: FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060405 4 1 wf-form4_164148067397164.xml FORM 4 X0306 4 2022-01-04 0 0001358403 BELLICUM PHARMACEUTICALS, INC BLCM 0001607052 Huber Reid M C/O BELLICUM PHARMACEUTICALS, INC. 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 1 0 0 0 Common Stock 2022-01-04 4 M 0 19494 0 A 19494 D Restricted Stock Units 2022-01-04 4 M 0 19494 0 D Common Stock 19494.0 0 D Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer common stock. The RSUs vest in full upon the one year anniversary of grant date on January 4, 2021. /s/ Richard A. Fair, Attorney-in-Fact 2022-01-06